Ok , study in vitro , if good results because of results with Maraviroc getting ready to apply for phase 2 , than they planning to skip in vivo animal study .
I don’t understand very well , dr NP said he will talk about financing in the future CC , May 22 is shareholder meeting not CC so how to understand that .,
Probably not May 22 ???